Argenica Therapeutics Ltd宣布,美国食品药品监督管理局要求进行的三项关键检测中,已有两项顺利完成。目前,符合良好实验室规范的hERG心脏安全性检测正在推进中。
Argenica Therapeutics Ltd宣布,美国食品药品监督管理局要求进行的三项关键检测中,已有两项顺利完成。目前,符合良好实验室规范的hERG心脏安全性检测正在推进中。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.